Consistent with this, NAD+ was at significantly lower abundance in CD45+ T cells than CD45− tumour cells in the dataset of purified cell populations (NAD+ log2 fold change = −1.22, P value = 1.7 × 10−4; Fig. 5f). This evidence concerns the gene PTPRC and neoplasm.